CompuGroup Medical and CVC plan delisting

CVC plans to launch a public delisting tender offer at a price of EUR22.00 in cash per share of CompuGroup Medical SE & Co. KGaA. This consideration corresponds to the offer price of the previous public takeover offer by CVC, which was published in December 2024 and completed on May 2, 2025. As early as December 9, 2024, CGM and CVC had announced their strategic partnership and plans for a subsequent delisting of CGM.

The managing directors, the supervisory board, and the administrative board of CompuGroup Medical expressly welcome the public delisting tender offer. The offer provides the company’s shareholders with the opportunity to sell their shares at an attractive price prior to the termination of the stock exchange listing, regardless of market liquidity. The planned withdrawal from the stock exchange will enable CGM to focus even more strongly on implementing its long-term innovation and growth strategy.

The public delisting tender offer is expected to be published in May 2025, with the acceptance period also expected to begin in May 2025. Completion of the delisting is anticipated within the first half of the 2025 financial year, but in any case, before the annual general meeting of CGM scheduled for August 1, 2025.

CompuGroup Medical SE & Co. KGaA is one of the leading e-health companies in the world, generating revenues of EUR1.15bn in 2025. With over 8,700 staff at locations in 19 countries, the company offers its products in 60 countries worldwide.

CVC is a leading global private markets manager with a network of 30 office locations throughout EMEA, the Americas and Asia, with approximately EUR200bn of assets under management. Funds managed or advised in line with CVC's private equity strategy are invested in approximately 140 companies worldwide, which have combined annual sales of over EUR168bn and employ more than 600,000 people.

The A&O Shearman team was led by partner Dr. Christian Eichner and senior associate Eva Hohmann, and also included counsel Kyrill Chilevych as well as associates Dr. Christina Vossen and Lasse Ostholt (all corporate/M&A, all Düsseldorf).

An A&O Shearman team led by Dr. Christian Eichner and Eva Hohmann had already advised the supervisory board as well as a part of members of the administrative board of CompuGroup Medical SE & Co. KGaA in connection with the previous public takeover offer by CVC.